| Typicality: | 0.459 |
| Saliency: | 0.490 |
| during the early phases | 4 | temporal |
| quickly | 2 | manner |
| in both the avastin | 2 | location |
| researcher → identify → side effects | 64 |
| researcher → identify → possible side effects | 5 |
| researcher → assess → side effects | 4 |
| researcher → identify → any side effects | 4 |
| researcher → evaluate → side effects | 3 |
| negative | neutral | positive |
| 0.061 | 0.860 | 0.079 |
| Raw frequency | 80 |
| Normalized frequency | 0.490 |
| Modifier score | 0.500 |
| Perplexity | 340.667 |